Cargando…

Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies

INTRODUCTION: Necrotizing autoimmune myopathies (NAM) have recently been defined as a distinct group of severe acquired myopathies, characterized by prominent myofiber necrosis without significant muscle inflammation. Because of the lack of appropriate biomarkers, these diseases have been long misdi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drouot, Laurent, Allenbach, Yves, Jouen, Fabienne, Charuel, Jean-Luc, Martinet, Jérémie, Meyer, Alain, Hinschberger, Olivier, Bader-Meunier, Brigitte, Kone-Paut, Isabelle, Campana-Salort, Emmanuelle, Eymard, Bruno, Tournadre, Anne, Musset, Lucile, Sibilia, Jean, Marie, Isabelle, Benveniste, Olivier, Boyer, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979083/ https://www.ncbi.nlm.nih.gov/pubmed/24484965 http://dx.doi.org/10.1186/ar4468

Ejemplares similares

Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies: Inconstant Exposure to Statin
por: Allenbach, Yves, et al.
Publicado: (2014)

Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial
por: Allenbach, Yves, et al.
Publicado: (2015)

Autoimmune Myopathies: Where Do We Stand?
por: Simon, Jean-Philippe, et al.
Publicado: (2016)

Th1 Response and Systemic Treg Deficiency in Inclusion Body Myositis
por: Allenbach, Yves, et al.
Publicado: (2014)

Prevention of Anti-HMGCR Immune-Mediated Necrotising Myopathy by C5 Complement Inhibition in a Humanised Mouse Model
por: Julien, Sarah, et al.
Publicado: (2022)

Analysis of Autoantibodies to 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Using Different Technologies
por: Musset, Lucile, et al.
Publicado: (2014)

MRI and muscle imaging for idiopathic inflammatory myopathies
por: Malartre, Samuel, et al.
Publicado: (2021)

Probing conformational states of glutaryl-CoA dehydrogenase by fragment screening
por: Begley, Darren W., et al.
Publicado: (2011)

Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1
por: Barroso, Madalena, et al.
Publicado: (2023)

The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in renal disease
por: Gomez, Sabas I, et al.
Publicado: (2014)

Biomarkers in Inflammatory Myopathies—An Expanded Definition
por: Benveniste, Olivier, et al.
Publicado: (2019)

Interaction of Glutaric Aciduria Type 1-Related glutaryl-CoA Dehydrogenase with Mitochondrial Matrix Proteins
por: Schmiesing, Jessica, et al.
Publicado: (2014)

Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors
por: Roy, Satyajeet, et al.
Publicado: (2017)

Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice
por: Bhatt, Dhaval P., et al.
Publicado: (2022)

Evaluation of Humoral Immunity to SARS-CoV-2: Diagnostic Value of a New Multiplex Addressable Laser Bead Immunoassay
por: Drouot, Laurent, et al.
Publicado: (2020)

Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy
por: Mohassel, Payam, et al.
Publicado: (2018)

In silico investigation on alkaloids of Rauwolfia serpentina as potential inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA reductase
por: Azmi, Muhammad Bilal, et al.
Publicado: (2021)

Functions and Mechanisms of Lysine Glutarylation in Eukaryotes
por: Xie, Longxiang, et al.
Publicado: (2021)

Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity
por: Mahoudeau, Alexandrine, et al.
Publicado: (2022)

Increased glutarate production by blocking the glutaryl-CoA dehydrogenation pathway and a catabolic pathway involving l-2-hydroxyglutarate
por: Zhang, Manman, et al.
Publicado: (2018)

A novel mutation in the glutaryl‐CoA dehydrogenase gene (GCDH) in an Iranian patient affected with Glutaric acidemia type 1
por: Rayat, Sima, et al.
Publicado: (2021)

Preparation of Affinity Purified Antibodies against ε-Glutaryl-Lysine Residues in Proteins for Investigation of Glutarylated Proteins in Animal Tissues
por: Artiukhov, Artem V., et al.
Publicado: (2021)

PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited
por: Knauss, Samuel, et al.
Publicado: (2019)

NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary Affection
por: Pawlitzki, Marc, et al.
Publicado: (2021)

Targeted suppression of glutaryl-CoA dehydrogenase by lentivirus-mediated SHRNA and excessive intake of lysine induce the apoptosis of rat striatal neurons
por: Jinzhi, Gao, et al.
Publicado: (2013)

High-Dimensional Cytometry Dissects Immunological Fingerprints of Idiopathic Inflammatory Myopathies
por: Nelke, Christopher, et al.
Publicado: (2022)

Beneficial Role of Rapamycin in Experimental Autoimmune Myositis
por: Prevel, Nicolas, et al.
Publicado: (2013)

Correction: Beneficial Role of Rapamycin in Experimental Autoimmune Myositis
por: Prevel, Nicolas, et al.
Publicado: (2014)

Effects of Targeted Suppression of Glutaryl-CoA Dehydrogenase by Lentivirus-Mediated shRNA and Excessive Intake of Lysine on Apoptosis in Rat Striatal Neurons
por: Gao, Jinzhi, et al.
Publicado: (2013)

Thrombophilia Associated with Anti-DFS70 Autoantibodies
por: Marlet, Julien, et al.
Publicado: (2015)

Behçet’s disease in children, an overview
por: Koné-Paut, Isabelle
Publicado: (2016)

Analysis of cell surface and intranuclear markers on non-stimulated human PBMC using mass cytometry
por: Dzangué-Tchoupou, Gaëlle, et al.
Publicado: (2018)

Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping
por: Huber, Adrian T., et al.
Publicado: (2018)

In Vitro Evaluation of Farnesyltransferase Inhibitor and its Effect in Combination with 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor against Naegleria fowleri
por: Hahn, Hye Jee, et al.
Publicado: (2020)

Sequestosome‐1 (p62) expression reveals chaperone‐assisted selective autophagy in immune‐mediated necrotizing myopathies
por: Fischer, Norina, et al.
Publicado: (2019)

Detection of subclinical cardiac involvement in inflammatory myopathy by CMR T1 relaxometry
por: Bravetti, Marine, et al.
Publicado: (2016)

IL-1 Inhibition May Have an Important Role in Treating Refractory Kawasaki Disease
por: Dusser, Perrine, et al.
Publicado: (2017)

Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic
por: Koné-Paut, Isabelle, et al.
Publicado: (2020)

Still’s Disease in the Constellation of Hyperinflammatory Syndromes: A Link with Kawasaki Disease?
por: Dusser, Perrine, et al.
Publicado: (2021)

Importance of predicting non-response to intravenous immunoglobulin therapy in non-Asian patients with Kawasaki disease
por: Koné-Paut, Isabelle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bsm9smbnhk472b8t9va6gjb0bv